Annual Current Liabilities
$156.22 M
+$63.92 M+69.24%
31 December 2023
Summary:
Esperion Therapeutics annual total current liabilities is currently $156.22 million, with the most recent change of +$63.92 million (+69.24%) on 31 December 2023. During the last 3 years, it has risen by +$62.16 million (+66.07%). ESPR annual current liabilities is now at all-time high.ESPR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$165.87 M
-$9.46 M-5.40%
30 September 2024
Summary:
Esperion Therapeutics quarterly total current liabilities is currently $165.87 million, with the most recent change of -$9.46 million (-5.40%) on 30 September 2024. Over the past year, it has increased by +$28.16 million (+20.45%). ESPR quarterly current liabilities is now -5.40% below its all-time high of $175.34 million, reached on 30 June 2024.ESPR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.2% | +20.4% |
| 3 y3 years | +66.1% | +111.3% |
| 5 y5 years | +142.8% | +188.4% |
ESPR Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +113.0% | -5.4% | +126.1% |
| 5 y | 5 years | at high | +142.8% | -5.4% | +188.4% |
| alltime | all time | at high | >+9999.0% | -5.4% | +6479.1% |
Esperion Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $165.87 M(-5.4%) |
| June 2024 | - | $175.34 M(+6.6%) |
| Mar 2024 | - | $164.51 M(+5.3%) |
| Dec 2023 | $156.22 M(+69.2%) | $156.22 M(+13.4%) |
| Sept 2023 | - | $137.71 M(+28.5%) |
| June 2023 | - | $107.17 M(+12.2%) |
| Mar 2023 | - | $95.49 M(+3.4%) |
| Dec 2022 | $92.31 M(+25.8%) | $92.31 M(+12.1%) |
| Sept 2022 | - | $82.34 M(+0.1%) |
| June 2022 | - | $82.28 M(+4.0%) |
| Mar 2022 | - | $79.08 M(+7.8%) |
| Dec 2021 | $73.35 M(-22.0%) | $73.35 M(-6.5%) |
| Sept 2021 | - | $78.48 M(-5.0%) |
| June 2021 | - | $82.64 M(-15.6%) |
| Mar 2021 | - | $97.89 M(+4.1%) |
| Dec 2020 | $94.07 M(+42.4%) | $94.07 M(+23.9%) |
| Sept 2020 | - | $75.95 M(-9.5%) |
| June 2020 | - | $83.88 M(+14.2%) |
| Mar 2020 | - | $73.45 M(+11.2%) |
| Dec 2019 | $66.08 M(+2.7%) | $66.08 M(+14.9%) |
| Sept 2019 | - | $57.52 M(+5.9%) |
| June 2019 | - | $54.31 M(-9.5%) |
| Mar 2019 | - | $60.02 M(-6.7%) |
| Dec 2018 | $64.33 M | $64.33 M(+52.1%) |
| Sept 2018 | - | $42.28 M(+20.9%) |
| June 2018 | - | $34.96 M(+16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $30.05 M(-9.3%) |
| Dec 2017 | $33.14 M(+112.6%) | $33.14 M(-5.3%) |
| Sept 2017 | - | $35.00 M(+12.9%) |
| June 2017 | - | $31.00 M(+43.5%) |
| Mar 2017 | - | $21.61 M(+38.6%) |
| Dec 2016 | $15.59 M(+177.1%) | $15.59 M(+91.0%) |
| Sept 2016 | - | $8.16 M(+6.9%) |
| June 2016 | - | $7.63 M(+27.4%) |
| Mar 2016 | - | $5.99 M(+6.5%) |
| Dec 2015 | $5.63 M(+2.4%) | $5.63 M(-17.6%) |
| Sept 2015 | - | $6.83 M(-2.9%) |
| June 2015 | - | $7.03 M(+1.3%) |
| Mar 2015 | - | $6.94 M(+26.4%) |
| Dec 2014 | $5.49 M(+30.6%) | $5.49 M(-2.5%) |
| Sept 2014 | - | $5.63 M(+3.2%) |
| June 2014 | - | $5.46 M(+71.1%) |
| Mar 2014 | - | $3.19 M(-24.1%) |
| Dec 2013 | $4.20 M(-75.5%) | $4.20 M(+25.7%) |
| Sept 2013 | - | $3.34 M(-49.7%) |
| June 2013 | - | $6.64 M(+163.5%) |
| Mar 2013 | - | $2.52 M(-85.3%) |
| Dec 2012 | $17.17 M(+1182.4%) | $17.17 M |
| Dec 2011 | $1.34 M(-72.9%) | - |
| Dec 2002 | $4.93 M(-22.4%) | - |
| Dec 2001 | $6.36 M(-11.2%) | - |
| Dec 2000 | $7.16 M(+146.9%) | - |
| Dec 1999 | $2.90 M | - |
FAQ
- What is Esperion Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Esperion Therapeutics?
- What is Esperion Therapeutics annual current liabilities year-on-year change?
- What is Esperion Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly current liabilities year-on-year change?
What is Esperion Therapeutics annual total current liabilities?
The current annual current liabilities of ESPR is $156.22 M
What is the all time high annual current liabilities for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total current liabilities is $156.22 M
What is Esperion Therapeutics annual current liabilities year-on-year change?
Over the past year, ESPR annual total current liabilities has changed by +$63.92 M (+69.24%)
What is Esperion Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ESPR is $165.87 M
What is the all time high quarterly current liabilities for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total current liabilities is $175.34 M
What is Esperion Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ESPR quarterly total current liabilities has changed by +$28.16 M (+20.45%)